243 related articles for article (PubMed ID: 15661032)
1. Genetic analysis of patients with defects in early B-cell development.
Conley ME; Broides A; Hernandez-Trujillo V; Howard V; Kanegane H; Miyawaki T; Shurtleff SA
Immunol Rev; 2005 Feb; 203():216-34. PubMed ID: 15661032
[TBL] [Abstract][Full Text] [Related]
2. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations.
Tao L; Boyd M; Gonye G; Malone B; Schwaber J
Hum Mutat; 2000 Dec; 16(6):528-9. PubMed ID: 11102984
[TBL] [Abstract][Full Text] [Related]
3. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
[TBL] [Abstract][Full Text] [Related]
4. Genotype/phenotype correlations in X-linked agammaglobulinemia.
Broides A; Yang W; Conley ME
Clin Immunol; 2006; 118(2-3):195-200. PubMed ID: 16297664
[TBL] [Abstract][Full Text] [Related]
5. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children.
Noordzij JG; de Bruin-Versteeg S; Comans-Bitter WM; Hartwig NG; Hendriks RW; de Groot R; van Dongen JJ
Pediatr Res; 2002 Feb; 51(2):159-68. PubMed ID: 11809909
[TBL] [Abstract][Full Text] [Related]
6. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlation in Bruton's tyrosine kinase deficiency.
Teimourian S; Nasseri S; Pouladi N; Yeganeh M; Aghamohammadi A
J Pediatr Hematol Oncol; 2008 Sep; 30(9):679-83. PubMed ID: 18776760
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia.
Nonoyama S; Tsukada S; Yamadori T; Miyawaki T; Jin YZ; Watanabe C; Morio T; Yata J; Ochs HD
J Immunol; 1998 Oct; 161(8):3925-9. PubMed ID: 9780159
[TBL] [Abstract][Full Text] [Related]
9. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
10. BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
Fiorini M; Franceschini R; Soresina A; Schumacher RF; Ugazio AG; Rossi P; Plebani A; Notarangelo LD
Hum Mutat; 2004 Mar; 23(3):286. PubMed ID: 14974089
[TBL] [Abstract][Full Text] [Related]
11. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia.
López-Granados E; Pérez de Diego R; Ferreira Cerdán A; Fontán Casariego G; García Rodríguez MC
J Allergy Clin Immunol; 2005 Sep; 116(3):690-7. PubMed ID: 16159644
[TBL] [Abstract][Full Text] [Related]
12. Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia.
Wang Y; Kanegane H; Sanal O; Ersoy F; Tezcan I; Futatani T; Tsukada S; Miyawaki T
Hum Mutat; 2001 Oct; 18(4):356. PubMed ID: 11668622
[TBL] [Abstract][Full Text] [Related]
13. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
[TBL] [Abstract][Full Text] [Related]
14. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
15. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia.
Kristufek D; Aspalter RM; Eibl MM; Wolf HM
Mol Immunol; 2007 Mar; 44(7):1639-43. PubMed ID: 17045652
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
[TBL] [Abstract][Full Text] [Related]
17. xid affects events leading to B cell cycle entry.
Brorson K; Brunswick M; Ezhevsky S; Wei DG; Berg R; Scott D; Stein KE
J Immunol; 1997 Jul; 159(1):135-43. PubMed ID: 9200448
[TBL] [Abstract][Full Text] [Related]
18. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
Kanegane H; Futatani T; Wang Y; Nomura K; Shinozaki K; Matsukura H; Kubota T; Tsukada S; Miyawaki T
J Allergy Clin Immunol; 2001 Dec; 108(6):1012-20. PubMed ID: 11742281
[TBL] [Abstract][Full Text] [Related]
19. Bruton's tyrosine kinase--an integral protein of B cell development that also has an essential role in the innate immune system.
López-Herrera G; Vargas-Hernández A; González-Serrano ME; Berrón-Ruiz L; Rodríguez-Alba JC; Espinosa-Rosales F; Santos-Argumedo L
J Leukoc Biol; 2014 Feb; 95(2):243-50. PubMed ID: 24249742
[TBL] [Abstract][Full Text] [Related]
20. Expression of Bruton's tyrosine kinase protein within the B cell lineage.
Genevier HC; Hinshelwood S; Gaspar HB; Rigley KP; Brown D; Saeland S; Rousset F; Levinsky RJ; Callard RE; Kinnon C
Eur J Immunol; 1994 Dec; 24(12):3100-5. PubMed ID: 7805739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
